Cure My Disease

Don't miss your cure!

 Log in / Sign up

New leg sleeve aims to stop deadly clots – but does it work?

NCT ID NCT07287007

Disease control Sponsor: Wellell Inc. Taiwan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device called VenAir that squeezes the legs to improve blood flow and prevent blood clots. About 105 healthy adults aged 20-64 will lie down while wearing different leg garments, and ultrasound will measure their blood flow. The goal is to see if VenAir works as well as a standard device already on the market.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
VenAir intermittent pneumatic compression device
What this could lead to
If it works, this could provide a new option for preventing dangerous blood clots in the legs and lungs.
What could go wrong
This is an early study in healthy people, not patients. It only measures blood flow, not actual clot prevention, so success here doesn't guarantee it prevents clots in real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 105 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 64 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy adults * Aged 20-64 years * Leg circumference within the size range of the SCD700 and VenAir garments Exclusion Criteria: * Cardiovascular-related diseases (mild atherosclerosis, other ischemic vascular diseases, congestive heart failure, etc.) * Previous suspicion of deep vein thrombosis, pulmonary embolism, or phlebitis * History of stroke * History of varicose vein surgery * Hypertension * Diabetes * Dermatitis, gangrene, or severe wounds * Massive edema of legs * Pregnancy * Pulmonary edema

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for No condition, healthy individuals are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

No condition, healthy individuals No conditions, aged 20-64

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Wellell Inc.

    RECRUITING

    New Taipei City, 236044, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.